Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase <i>FIP1L1-PDGFRA</i>-Associated Myeloid Neoplasm With Eosinophilia.

Jain, Juhi; Weinzierl, Elizabeth P; Saxe, Debra; Bergsagel, John; Gotlib, Jason; Reiter, Andreas; Raikar, Sunil S

Sustained Complete Molecular Remission With Imatinib Monotherapy in a Child Presenting With Blast Phase FIP1L1-PDGFRA-Associated Myeloid Neoplasm With Eosinophilia.

Jain, Juhi; Weinzierl, Elizabeth P; Saxe, Debra; Bergsagel, John; Gotlib, Jason; Reiter, Andreas; Raikar, Sunil S.

Afiliação

Jain J; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA.
Weinzierl EP; Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
Saxe D; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
Bergsagel J; Department of Pathology and Laboratory Medicine, Emory University, Atlanta, Georgia, USA.
Gotlib J; Department of Pediatrics, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University, Atlanta, Georgia, USA.
Reiter A; Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California, USA.
Raikar SS; Department of Hematology and Oncology, University Hospital Mannheim, Mannheim, Germany.

Hemasphere ; 4(6): e486, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33196011

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Hemasphere Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google